Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In early 1990 fluconazole was introduced as a prophylactic antifungal agent after bone marrow transplantation. During the same year Candida krusei emerged as the chief candida pathogen among patients with bone marrow transplants. METHODS: To determine whether there was a correlation between the introduction of fluconazole and the increased incidence of C. krusei, we conducted a retrospective study based on the medical, mycologic, and autopsy records of all adult inpatients who had undergone bone marrow transplantation (n = 296) or who had leukemia (n = 167) at the study center during 1989 and 1990. RESULTS: The 84 patients who received antifungal prophylaxis with fluconazole had a sevenfold greater frequency of C. krusei infection than the 335 patients who did not receive fluconazole (8.3 percent vs. 1.2 percent, P = 0.002), despite having a lower frequency of disseminated C. albicans and C. tropicalis infections (0 vs. 6.0 percent, P = 0.02). Ten of the 11 C. krusei infections were controlled by a combination of amphotericin B and flucytosine. Colonization by C. krusei was found in 40.5 percent of the patients who received fluconazole but in only 16.7 percent of those who did not receive it (P less than 0.0001). Colonization was independently associated with the prophylactic use of both fluconazole (odds ratio, 3.50; P less than 0.001) and norfloxacin (odds ratio, 2.53; P = 0.04). C. krusei was not susceptible to fluconazole in vitro. CONCLUSIONS: In patients at high risk for disseminated candida infections, suppression of bacterial flora and the more common candida pathogens may permit some less pathogenic, but natively resistant candida species, such as C. krusei, to emerge as systemic pathogens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This phenomenon was first reported in the United States in neutropenic recipients of bone marrow transplants [9].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [9]
In the citing paper
“C. lusitaniae has been shown to exhibit highfrequency phenotypic switching from amphotericin B susceptibility to resistance upon exposure to the drug (160, 324).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [324]
Citations
Cites
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy
Horn, R., Wong, B., Kiehn, T. E., & Armstrong, D. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.5.646 · Cited by 480
Komshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Hughes, W. T., Armstrong, D., Bodey, G. R., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.3.381 · Cited by 403
Empiric antifungal therapy in febrile granulocytopenic patients
(1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90441-5 · Cited by 378
Adherence of Candida albicans and other Candida species to mucosal epithelial cells
King, R. D., Lee, J. C., & Morris, A. L. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.667-674.1980 · Cited by 313
Candida tropicalis: A Major Pathogen in Immunocompromised Patients
WINGARD, J. R., MERZ, W. G., & SARAL, R. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-4-539 · Cited by 294
Self-citationIncidence of polyene-resistant yeasts recovered from clinical specimens
Dick, J. D., Merz, W. G., & Saral, R. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.1.158 · Cited by 242
Self-citationThe Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal Infections
Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P., & Saral, R. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.4.503 · Cited by 215
Self-citationCandida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance
Merz, W. G. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.20.6.1194-1195.1984 · Cited by 166
Self-citation
Research works printed but not linked: 2
- 1990, J Infect Dis, 161, 1316
- Persons, 1991, N Engl J Med, 325, 1315
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956
“This likely reflects, in part, selective pressure because of the extensive use of prophylactic fluconazole in susceptible hosts [32, 33].”
Background
Metadata
- Authors
- Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R.
- Affiliations
- Johns Hopkins University (US)
- Emory University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1991-10-31
- Volume
- 325
- Issue
- 18
- Pages
- 1274-1277
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339375844
- Cited by
- 937
- References
- 20
- Citations by year
- 2025: 3 · 2024: 10 · 2023: 2 · 2022: 7 · 2021: 7 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 13 · 2016: 8 · 2015: 13 · 2014: 17 · 2013: 5 · 2012: 19
- FWCI
- 45.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA15396, CA06973, P01CA015396, P30CA006973)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Candida krusei, fluconazole, antifungal prophylaxis, bone marrow transplantation, neutropenia, candidiasis, fungal colonization, norfloxacin, amphotericin B, 5-fluorocytosine, Candida albicans, Candida tropicalis, drug resistance, leukemia
- MeSH terms
- Adult, Amphotericin B, Candidiasis, Drug Therapy, Combination, Humans, Leukemia, Mycoses, Opportunistic Infections, Postoperative Complications, Retrospective Studies, Fluconazole, Bone Marrow Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole. https://app.cochat.ai/papers/10.1056/nejm199110313251803
- The paper
- Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991). Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole. New England Journal of Medicine. https://doi.org/10.1056/nejm199110313251803
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.